LXU Financial Statements & Analysis
Complete financial statements for LXU including income statement, balance sheet, and cash flow statement. Analyze LXU's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
17.8% ↑
Net Income
227.2% ↑
Gross Margin
85.3% ↑
Operating Margin
1068.6% ↑
Balance Sheet
Current Ratio
21.7% ↑
Debt to Equity
-12.1% ↑
Asset Turnover
19.1% ↑
Cash Flow
Operating Cash Flow
10.3% ↑
Net Cash Flow
99.1% ↑
Free Cash Flow
415.9% ↑
Cash Flow to Debt
18.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 522.40M | 615.21M | 17.8% | |
| Gross Profit | 47.80M | 104.30M | 118.2% | |
| Operating Income | -5.50M | 62.80M | 1240.7% | |
| Net Income | -19.35M | 24.61M | 227.2% | |
| EPS | -0.27 | 0.34 | 225.9% | |
| EBITDA | 82.69M | 145.14M | 75.5% | |
| Gross Margin | 9.15% | 16.95% | 85.3% | |
| Operating Margin | -1.05% | 10.21% | 1068.6% | |
| Net Income Margin | -3.70% | 4.00% | 208.0% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 615.21M | 522.40M | 593.71M | — | — |
| Gross Profit | 104.30M | 47.80M | 86.26M | — | — |
| Operating Income | 62.80M | -5.50M | 51.78M | — | — |
| Net Income | 24.61M | -19.35M | 27.92M | — | — |
| EPS | 0.34 | -0.27 | 0.37 | — | — |
| EBITDA | 145.14M | 82.69M | 143.95M | — | — |
| Gross Margin | 16.95% | 9.15% | 14.53% | — | — |
| Operating Margin | 10.21% | -1.05% | 8.72% | — | — |
| Net Income Margin | 4.00% | -3.70% | 4.70% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into LXU's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics